r-primaquine
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 17, 2018 (NCT03934450)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Plasmodium vivaxINHIBITOR
Plasmodium vivax inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04073953 | Phase 1 | Sep 1, 2019 | Southern Research, University of Colorado, Denver, University of Mississippi |
| NCT03934450 | Phase 1 | Aug 17, 2018 | University of Mississippi |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Mississippi | Academic/Hospital | 2 | 2 | 1 | 2018 |
| Southern Research | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Colorado, Denver | Academic/Hospital | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1